↓ Skip to main content

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Overview of attention for article published in Radiation Oncology, April 2012
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
Published in
Radiation Oncology, April 2012
DOI 10.1186/1748-717x-7-57
Pubmed ID
Authors

Alexandra D Jensen, Jürgen Krauss, Karin Potthoff, Christian Simon, Anna V Nikoghosyan, Karen Lossner, Jürgen Debus, Marc W Münter

Abstract

To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated radiation therapy (IMRT) in a concomitant boost concept.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
Japan 1 <1%
France 1 <1%
Unknown 104 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 18%
Student > Master 16 15%
Student > Ph. D. Student 12 11%
Student > Bachelor 11 10%
Other 9 8%
Other 18 17%
Unknown 23 21%
Readers by discipline Count As %
Medicine and Dentistry 39 36%
Nursing and Health Professions 9 8%
Biochemistry, Genetics and Molecular Biology 8 7%
Physics and Astronomy 6 6%
Agricultural and Biological Sciences 4 4%
Other 12 11%
Unknown 30 28%